SLU-PP-332 5mg – Licensed Peptides

SLU-PP-332 is an investigational compound under study for its ability to reproduce some of the physiological effects typically associated with exercise. Its mechanism of action involves activation of estrogen-related receptors (ERRα, ERRβ, and ERRγ), which are central regulators of energy metabolism. Through this pathway, the compound has been shown to enhance mitochondrial efficiency, increase fatty acid oxidation, and elevate overall energy expenditure. In preclinical studies involving both diet-induced and genetically obese mice, administration of SLU-PP-332 produced significant metabolic improvements. Animals receiving the compound demonstrated reduced fat mass and greater rates of fatty acid utilization, while food intake and physical activity remained unchanged. These findings suggest that the compound alters systemic energy balance, creating a more favorable metabolic profile without requiring lifestyle modification. Additional investigations have highlighted the compound’s effects on skeletal muscle physiology. Treatment was associated with a higher proportion of oxidative muscle fibers, a shift that supports endurance capacity. Functional outcomes reflected this change, as mice receiving SLU-PP-332 exhibited prolonged exercise tolerance. Mechanistic studies attributed these effects to enhanced mitochondrial respiration and improved cellular bioenergetics within muscle tissue.